Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Clinical pharmacology and therapy

• Publication date

  1971-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cpt1971122part2323PMID 4930865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.

  1970cited by this paper
• [Treatment of Parkinson's disease by L-DOPA].

  1969cited by this paper
• Treatment of parkinsonism with levodopa.

  1969cited by this paper
• Aromatic amino acids and modification of parkinsonism.

  1967cited by this paper

• Levodopa: A Review of its Pharmacological Properties and Therapeutic Uses with Particular Reference to Parkinsonism

  2012cites this paper
• Treatment of Parkinson's syndrome with l-DOPA on an out-patient basis

  2004cites this paper
• Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

  2001cites this paper
• [Drug-induced alopecia: review of the literature].

  1995cites this paper
• L-dopa treatment and Parkinson's disease.

  1986cites this paper
• Tyrosine for the Treatment of Depression

  1984cites this paper
• Stress: Its Effect on Interactions among Biogenic Amines and Role in the Induction and Treatment of Disease

  1984cites this paper
• Clinical Utilization of Alkaline Phosphatase Measurements

  1979cites this paper
• [Autoimmune hemolytic anemia in a Parkinsonian treated with a combination of L-dopa and carbidopa].

  1977cites this paper
• Effect of levodopa on urinary bladder.

  1976cites this paper
• Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients.

  1975cites this paper
• [Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor)].

  1975cites this paper
• [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

  1974cites this paper
• [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].

  1974cites this paper
• Parkinson's disease and levodopa. A five-year follow-up and review.

  1974cites this paper
• Zur differentiellen Therapie des Morbus Parkinson unter besonderer Berücksichtigung von iatrogenen Schädigungsmöglichkeiten

  1974cites this paper
• 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.

  1973cites this paper
• External work of walking and functional capacity in Parkinsonian patients treated with L-dopa.

  1972cites this paper
• Levodopa and surgical anesthesia

  1972cites this paper
• Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.

  1972cites this paper
• Occurrence of positive Coombs test in patients treated with levodopa.

  1972cites this paper
• Combined L-dopa and amantadine in Parkinsonism.

  1972cites this paper
• Methyldopahydrazine as an adjunct to L‐dopa therapy in parkinsonism

  1972cites this paper
• Parkinsonism, levodopa, and anesthesia.

  1972cites this paper
• [Cardio-vascular effects of L-dopa].

  1972cites this paper
• L-dopa in the treatment of Parkinsonism.

  1972cites this paper
• The management of Parkinson's syndrome.

  1972cites this paper
• Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndrome

  1972cites this paper
• Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment.

  1971cites this paper
• Cardiovascular effects of levodopa

  1971cites this paper